Vitrase

Vitrase is a brand name of hyaluronidase, approved by the FDA in the following formulation(s):

VITRASE (hyaluronidase - injectable; injection)

• 
  Manufacturer: ISTA PHARMS
  
  Approval date: December 2, 2004
  
  Strength(s): 200 UNITS/VIAL ^[RLD]

Has a generic version of Vitrase been approved?

No. There is currently no therapeutically equivalent version of Vitrase available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vitrase. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Vitrase.

See also...

• Vitrase Consumer Information (Drugs.com)
• Vitrase Consumer Information (Wolters Kluwer)
• Vitrase injectable Consumer Information (Cerner Multum)
• Vitrase Advanced Consumer Information (Micromedex)
• Hyaluronidase Consumer Information (Wolters Kluwer)
• Hyaluronidase injectable Consumer Information (Cerner Multum)
• Hyaluronidase Subcutaneous, Injection Advanced Consumer Information (Micromedex)